About Ebixa
Overcoming everyday challenges in Alzheimer’s disease
Ebixa is an effective, safe and well tolerated therapy, that helps overcome the everyday challenges in Alzheimer’s disease, easing the lives of both patients and their carers. Ebixa is indicated for the treatment of moderate to severe Alzheimer’s disease.
Ebixa is a specific, uncompetitive NMDA-receptor antagonist, with a novel mechanism of action that targets the glutamatergic signalling in the brain.
Please use the left-hand menu to access more detailed information about the benefits of Ebixa in Alzheimer’s disease.